CERO THERAPEUTICS HOLDINGS, INC. Fair Value Adjustment of Warrants
CERO THERAPEUTICS HOLDINGS, INC. (CERO) had Fair Value Adjustment of Warrants of $700.00 thousand as of 2025-01-06, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-04-15
- CERO THERAPEUTICS HOLDINGS, INC. fair value adjustment of warrants for the quarter ending 2024-09-30 was -$170.00K.
- CERO THERAPEUTICS HOLDINGS, INC. fair value adjustment of warrants for the quarter ending 2024-06-30 was -$2.90M.
- CERO THERAPEUTICS HOLDINGS, INC. fair value adjustment of warrants for the quarter ending 2023-12-31 was $110.06K.
- CERO THERAPEUTICS HOLDINGS, INC. fair value adjustment of warrants for the quarter ending 2023-09-30 was -$186.07K.
- CERO THERAPEUTICS HOLDINGS, INC. fair value adjustment of warrants for fiscal 2023 was -$301.17K.
| Period end | Fair Value Adjustment of Warrants | Fair Value Adjustment of Warrants 1 month | Fair Value Adjustment of Warrants 2 month | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 5 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 8 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 11 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-06 | $700.00K 10-K · filed 2026-04-15 | |||||||||
| 2024-12-31 | -$4.88M 10-K · filed 2025-04-15 | |||||||||
| 2024-12-23 | $300.00K 10-K · filed 2026-04-15 | |||||||||
| 2024-09-30 | -$170.00K 10-Q · filed 2025-11-19 | -$3.07M derived: sum of 2 quarters · filed 2025-11-19 | -$4.87M 10-Q · filed 2025-11-19 | |||||||
| 2024-06-30 | -$2.90M 10-Q · filed 2025-08-22 | -$4.70M 10-Q · filed 2025-08-22 | ||||||||
| 2024-03-31 | -$1.80M 10-Q · filed 2024-05-17 | |||||||||
| 2024-02-13 | -$320.12K 10-Q · filed 2025-11-19 | |||||||||
| 2023-12-31 | $110.06K derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-04-15 | -$76.01K derived: sum of 2 quarters · filed 2025-04-15 | -$337.83K derived: sum of 3 quarters · filed 2025-04-15 | -$301.17K 10-K · filed 2025-04-15 | ||||||
| 2023-09-30 | -$186.07K 10-Q/A · filed 2024-11-20 | -$447.89K derived: sum of 2 quarters · filed 2024-11-20 | -$411.23K 10-Q/A · filed 2024-11-20 | |||||||
| 2023-06-30 | -$261.82K 10-Q/A · filed 2024-11-20 | -$225.16K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |